U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07079657) titled 'Thulium Laser and Growth Factors for Androgenetic Alopecia' on July 13.
Brief Summary: Androgenetic alopecia (AGA) is a common cause of hair loss worldwide. It mainly affects the frontal and parietal regions of the scalp in up to 70 % of men and 40 % of women and has a significant negative psychological and emotional impact on those affected.
Various therapies are currently approved for the treatment of AGA in men and women, including topical minoxidil, topical or systemic finasteride, platelet-rich plasma and hair transplantation. In addition to these pharmacological and surgical interventions, laser therapies including thulium la...